About Lewis Williams
Form D filings for Eureka Therapeutics in 2018 list Lewis Williams as director.
Lewis Williams first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Lewis Williams in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lewis Williams works with at each company, as listed on that company's latest Form D.
Eureka Therapeutics, Inc. · Form D, Jun 18, 2018
CL
Christopher Lehman
Executive officer
BF
Bo Feng
Director
CC
Chih-Kai "C.K." Cheng
Director
MC
Michael Cannon
Director
BN
Bijan Nejadnik
Executive officer
WI
William Solari III
Director
VS
Victor Shum
General Counsel
WC
Wai-Yan "Sandy" Chau
Director
CL
Cheng Liu
Executive officer and director